Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 12-2019 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5 | -80,324 | -119,857 | 3,427,000 | 2,495,000 |
| Depreciation Amortization | 0 | 9,860 | 10,755 | 592,000 | 433,000 |
| Income taxes - deferred | N/A | N/A | N/A | 90,000 | 207,000 |
| Accounts receivable | N/A | -6,784 | N/A | -132,000 | -31,000 |
| Accounts payable and accrued liabilities | N/A | 2,700 | N/A | N/A | N/A |
| Other Working Capital | 0 | -13,219 | 10,577 | -204,000 | -650,000 |
| Other Operating Activity | 5 | 11,276 | 53,862 | 182,000 | 26,000 |
| Operating Cash Flow | $0 | $-76,491 | $-44,663 | $3,955,000 | $2,480,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -38,408 | -22,219 | -751,000 | -569,000 |
| Purchase Of Investment | N/A | N/A | N/A | -2,980,000 | -1,314,000 |
| Sale Of Investment | N/A | N/A | N/A | 2,049,000 | 1,210,000 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 15,000 | 22,000 |
| Other Investing Activity | 0 | 117 | -52,383 | 15,000 | 22,000 |
| Investing Cash Flow | $0 | $-38,291 | $-74,602 | $-1,667,000 | $-651,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -99,000 | N/A |
| Debt Repayment | N/A | -555 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 19 | N/A | 680,000 | 632,000 |
| Common Stock Repurchased | N/A | N/A | N/A | -780,000 | -756,000 |
| Other Financing Activity | 0 | 91,040 | 410,385 | -70,000 | 56,000 |
| Financing Cash Flow | $0 | $90,504 | $410,385 | $-269,000 | $-68,000 |
| Beginning Cash Position | 0 | 498,510 | 207,390 | 2,514,000 | 2,514,000 |
| End Cash Position | 0 | 474,232 | 498,510 | 4,533,000 | 4,275,000 |
| Net Cash Flow | $0 | $-24,278 | $291,120 | $2,019,000 | $1,761,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | -76,491 | -44,663 | 3,955,000 | 2,480,000 |
| Capital Expenditure | N/A | -38,408 | N/A | -751,000 | -569,000 |
| Free Cash Flow | 0 | -114,899 | -44,663 | 3,204,000 | 1,911,000 |